A new project in the field of biotechnology, telemedicine, clinical research and medical services is completing preparations for pre-ICO. Open Longevity is being developed to organize research on aging therapies in humans through the provision of advisory services to users. The ultimate goal is to find and introduce effective methods of radical life extension into clinical practice. Therefore, our tokens are called YEAR. Creating a platform, we combine the capabilities of modern IT-systems, the expertise of leading scientific analysts and the concernment of the patients themselves—members of Open Longevity community and future users of our online platform. It is important to note another driving force of the project—its openness and rejection of commercial benefits in those matters where this can affect the objectivity of scientific research. We are sure that effective ways to delay the onset of old age will be found—it is only a matter of time. Open Longevity wants to accelerate scientific research by involving a large number of people in clinical trials of aging therapies and creating an online platform for people to monitor health status, receive necessary recommendations from gerontologists, nutritionists and physicians to form a personal strategy for improving and preserving health.